A Strategy to Neutralize the Threat of Bioterrorism
We have new technology for safer vaccine development that will soon lead the way to protection for the entire U.S. population from bioterrorism threats. Public health benefits will accrue, as well. This new technology is cheaper, safer and takes much less production time than current practices. It's a particular type of plant science known as Transient Gene Expression (TGE).

click here for more

Fraunhofer CMB forms customized strategic alliances with industry leaders in pharmaceuticals, vaccines, enzymes and chemicals.

click here for more

Learn more about our process by viewing a short video (Windows Media Player required).